Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Trial Identifier: CIN-107-130
Sponsor: AstraZeneca
NCTID:: NCT05459688
Start Date: April 2022
Primary Completion Date: November 2023
Study Completion Date: November 2023
Condition: Hypertension

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, AL Saraland, AL, US, 36571
US, CA Huntington Park, CA, US, 90255
US, CA Lincoln, CA, US, 95648
US, CA Los Angeles, CA, US, 90057
US, CA Northridge, CA, US, 91324
US, CA Oceanside, CA, US, 92056
US, CA Panorama City, CA, US, 91402
US, CA Van Nuys, CA, US, 91405
US, FL Clearwater, FL, US, 33765
US, FL Doral, FL, US, 33166
US, FL Hialeah, FL, US, 33012
US, FL Hollywood, FL, US, 33024
US, FL Lake Worth, FL, US, 33467
US, FL Miami, FL, US, 33165
US, FL Miami, FL, US, 33173
US, FL Pembroke Pines, FL, US, 33027
US, FL Winter Haven, FL, US, 33880
US, IL Addison, IL, US, 60101
US, IL Chicago, IL, US, 60607
US, IL Morton, IL, US, 61550
US, IN Brownsburg, IN, US, 46112
US, LA New Orleans, LA, US, 70124
US, MI Troy, MI, US, 48085
US, MS Olive Branch, MS, US, 38654
US, NY Brooklyn, NY, US, 11235
US, OH Columbus, OH, US, 43213
US, OK Edmond, OK, US, 73013
US, TX Austin, TX, US, 78705
US, TX Carrollton, TX, US, 75006
US, TX Dallas, TX, US, 75234
US, TX Georgetown, TX, US, 78628
US, TX Houston, TX, US, 77040
US, TX Lampasas, TX, US, 76550
US, TX San Antonio, TX, US, 78209
US, UT West Valley City, UT, US, 84120
US, VA Manassas, VA, US, 20110